| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/09/2011 | CN101272793B Sphingomyelin-containing medicine, food and drink or fodder |
| 02/09/2011 | CN101269131B Traditional Chinese medicine for treating rheumatism paralysis |
| 02/09/2011 | CN101254264B Pharmaceutical combination for curing dysmenorrheal, preparation and quality control method |
| 02/09/2011 | CN101229353B Medicine compounds for treating rheumatoid and atrophic arthritis |
| 02/09/2011 | CN101181315B New purpose of Yulangsan polysaccharide |
| 02/09/2011 | CN101161251B Teasel root total saponin as well as its extracting method and application |
| 02/08/2011 | USRE42126 system for delivering oral care substance to oral cavity comprising a removable backing strip having sufficient flexibility to be conformable to oral surface and oral care composition that forms film when applied to backing strip comprising organosiloxane resin, rheology modifier, and oral care substance |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7884133 cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
| 02/08/2011 | CA2456604C Pharmaceutical composition comprising lumiracoxib |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics |
| 02/08/2011 | CA2403900C Substituted chalcones as therapeutic compounds |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/03/2011 | WO2011014600A1 Methods of treating neuropathic pain with benzimidazole derivative agonists of ppargamma |
| 02/03/2011 | WO2011014515A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors |
| 02/03/2011 | WO2011014261A1 Fatty acids as anti-inflammatory agents |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative |
| 02/03/2011 | WO2011013729A1 Fused imidazole derivative having ttk inhibitory action |
| 02/03/2011 | WO2011013359A1 Medicinal composition for iontophoresis |
| 02/03/2011 | WO2011013106A1 Lactic acid bacteria and bifidobacteria for treating endotoxemia |
| 02/03/2011 | WO2011013002A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 02/03/2011 | WO2011012883A1 Benzo [e] [1, 3 ] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors |
| 02/03/2011 | WO2011012868A1 Compounds for treatment of inflammation |
| 02/03/2011 | WO2011012810A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |
| 02/03/2011 | WO2011012661A1 Pyridine and pyrazine derivatives as protein kinase modulators |
| 02/03/2011 | WO2011012540A1 Tricyclic inhibitors of jak |
| 02/03/2011 | WO2011012283A1 Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event |
| 02/03/2011 | WO2011012075A1 Substituted phenyl piperazinyl aralkylone derivatives and its application for preparing analgesic drugs |
| 02/03/2011 | WO2011011965A1 Luteinising hormone releasing hormone antagonist with hydantoin structure |
| 02/03/2011 | WO2011011882A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
| 02/03/2011 | WO2010123832A3 2-oxamide inhibitors of phospholipase a2 activity and cellular arachidonate release based on dipeptides and pseudopeptides |
| 02/03/2011 | WO2010111178A3 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| 02/03/2011 | WO2009142571A8 Phenyl and benzodioxinyl substituted indazoles derivatives |
| 02/03/2011 | US20110030073 Therapeutic targets and medicaments involving p230/golgin-245 |
| 02/03/2011 | US20110028562 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 02/03/2011 | US20110028559 Substituted fluoroethyl ureas as alpha 2 adrenergic agents |
| 02/03/2011 | US20110028558 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | US20110028557 Treating patients with intravenous ibuprofen |
| 02/03/2011 | US20110028556 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | US20110028555 Antiinflammatory and Analgesic Preparation for External Use |
| 02/03/2011 | US20110028553 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | US20110028552 Mexiletine amino acid and peptide prodrugs and uses thereof |
| 02/03/2011 | US20110028522 Fullerene therapies for inflammation |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028502 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | US20110028490 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake in-hibitors |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028469 Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028460 Topical formulation |
| 02/03/2011 | US20110028457 Pharmaceutical preparation comprising permethylated cyclodextrin |
| 02/03/2011 | US20110028448 Pyridine compounds |
| 02/03/2011 | US20110028447 Indazole derivatives |
| 02/03/2011 | US20110028442 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
| 02/03/2011 | US20110028431 Oral mucoadhesive dosage form |
| 02/03/2011 | US20110028428 Hirsutella sinensis mycelia compositions and methods for treating sepsis and related inflammatory responses |
| 02/03/2011 | US20110028417 Macrocyclic Compounds and Methods of Use Thereof |
| 02/03/2011 | US20110028405 Sulfamides as zap-70 inhibitors |
| 02/03/2011 | US20110028400 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 02/03/2011 | US20110028399 Citrullinated cytokines |
| 02/03/2011 | US20110027389 Low Viscosity Liquid Polymeric Delivery System |
| 02/03/2011 | US20110027379 Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use |
| 02/03/2011 | US20110027365 Patch Formulation For External Use |
| 02/03/2011 | US20110027364 Bioactive and resorbable soybean-based biomaterials |
| 02/03/2011 | US20110027356 Combination of Oral Medicaments Bonded by a Wrapping |
| 02/03/2011 | US20110027348 Composition and method inhibiting inflammation |
| 02/03/2011 | US20110027342 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | US20110027331 An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation |
| 02/03/2011 | US20110027327 Cosmetic or pharmaceutical composition for topical application |
| 02/03/2011 | US20110027301 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027285 Methods and agents modulating upa/upar activity |
| 02/03/2011 | US20110027271 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 02/03/2011 | US20110027269 14-3-3 Antagonists for the Prevention and Treatment of Arthritis |
| 02/03/2011 | US20110027263 Soluble interleukin-20 receptor |
| 02/03/2011 | US20110027259 Component of bromelain |
| 02/03/2011 | US20110027256 Fusion proteins |
| 02/03/2011 | US20110027238 Mesenchymal Stem Cells and Uses Therefor |
| 02/03/2011 | US20110027236 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases |
| 02/03/2011 | US20110027220 Interleukin-1 Conjugates and Uses Thereof |
| 02/03/2011 | US20110027209 Compositions Containing Cyclic Peptides And Methods Of Use |
| 02/03/2011 | US20110027193 Compositions and methods for the treatment of inflammatory conditions |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110023870 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same |
| 02/03/2011 | DE102009034308A1 Medizinisches Präparat zur Behandlung von entzündlichen Prozessen Medicinal preparation for the treatment of inflammatory processes |
| 02/03/2011 | CA2769624A1 Fatty acids as anti-inflammatory agents |
| 02/03/2011 | CA2769541A1 Compounds for treatment of inflammation |
| 02/03/2011 | CA2769508A1 Methods of treating neuropathic pain with benzimidazole derivative agonists of ppargamma |
| 02/03/2011 | CA2769298A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 02/03/2011 | CA2769008A1 A pharmaceutical composition for an iontophoresis |